General presentation of Jaguar Health
In order to help you perform good analysis of Jaguar Health stock, we now offer a detailed presentation of this company. It is essential to understand how this company generates revenue in order to anticipate any changes in its growth over the long term.
Jaguar Health Inc. is an American company operating in the pharmaceutical sector. More specifically, the company specializes in the natural products segment.
In more detail, Jaguar Health specializes in the development and sale of new, sustainably derived gastrointestinal products for both humans with prescription drugs and animals. These products are marketed worldwide.
In addition, through its subsidiary Napo Pharmaceuticals Inc., the group focuses on the development and commercialization of gastrointestinal pharmaceuticals for humans and the global market. These products are based on plants that are traditionally used in tropical forest areas.
Among the leading products developed by the group is Mytesi, an antidiarrheal prescribed to relieve the symptoms of non-infectious diarrhea in adult patients suffering from HIV or Human Immunodeficiency Virus or AIDS or Acquired Immune Deficiency Syndrome and on antiretroviral therapy. Its product portfolio also includes treatments such as Canalevia, Equilevia, Neonorm Calf and Neonorm Foal.
The group currently employs 34 people.
67% of retail investor accounts lose money when trading CFDs with this provider. This is an advert for trading CFDs on eToro